Published in Am J Reprod Immunol Microbiol on January 01, 1986
Humoral immune response to an allogenic foetus in normal fertile women and recurrent aborters. BMC Pregnancy Childbirth (2002) 0.79
A default mode of brain function. Proc Natl Acad Sci U S A (2001) 50.73
Practice-related changes in human brain functional anatomy during nonmotor learning. Cereb Cortex (1994) 4.79
Influence of coexisting disease on survival on renal-replacement therapy. Lancet (1993) 4.12
AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett (1999) 3.63
MRI can prevent unnecessary arthroscopy. J Bone Joint Surg Br (1997) 3.48
Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man. Gut (1983) 3.46
Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem (2001) 2.56
Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2009) 2.11
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
Magnetic resonance imaging pelvimetry: a useful adjunct in the management of the obese patient. Br J Obstet Gynaecol (1992) 2.02
Acute renal failure requiring renal replacement therapy: incidence and outcome. QJM (2002) 2.00
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Integrated dialysis and renal transplantation: small is beautiful. Br Med J (1980) 1.85
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76
Successful transfer of a large island flap from the groin to the foot by microvascular anastomoses. Plast Reconstr Surg (1973) 1.74
Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol (1999) 1.74
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease. Cochrane Database Syst Rev (2007) 1.67
Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans. Gastroenterology (1982) 1.66
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57
Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant (2001) 1.55
Chronic renal failure: factors influencing nephrology referral. QJM (1994) 1.54
The epidemiology of shoulder dislocations. Arch Orthop Trauma Surg (1989) 1.53
Maternal body mass index in early pregnancy and offspring asthma, rhinitis and eczema up to 16 years of age. Clin Exp Allergy (2015) 1.53
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther (2015) 1.51
Thumb reconstruction with a free neurovascular wrap-around flap from the big toe. J Hand Surg Am (1980) 1.50
Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther (2006) 1.49
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47
Antenatal screening for diabetes mellitus. Br J Obstet Gynaecol (1984) 1.47
Urinary tract infection in old age. Br J Hosp Med (1989) 1.43
Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study. Nephrol Dial Transplant (2000) 1.43
Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia (2006) 1.42
The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis. EMBO Rep (2000) 1.41
A serial study of changes occurring in the oral glucose tolerance test during pregnancy. J Obstet Gynaecol Br Commonw (1973) 1.41
Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy (2012) 1.41
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40
Temporally resolved electro-optic effect. Opt Lett (2006) 1.38
Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. N Engl J Med (1984) 1.36
Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol (1997) 1.36
Fetal heart rate monitoring during labour--too frequent intervention, too little benefit? Lancet (1987) 1.36
Tetrahydropyridyloxadiazoles: semirigid muscarinic ligands. J Med Chem (1991) 1.29
AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location. FEBS Lett (1997) 1.28
An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition. J Pharmacol Exp Ther (2005) 1.28
Red cell mass during and after normal pregnancy. Br J Obstet Gynaecol (1979) 1.28
Human factor H-related protein 5 (FHR-5). A new complement-associated protein. J Biol Chem (2000) 1.26
Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol (1984) 1.26
Accelerated atherosclerosis in long-term dialysis and renal-transplant patients: fact or fiction? Lancet (1980) 1.21
Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells. Am J Physiol Renal Physiol (2000) 1.18
New index for evaluation of oral glucose tolerance test results. Br Med J (1973) 1.17
Nitric oxide in the kidney: functions and regulation of synthesis. Acta Physiol (Oxf) (2006) 1.17
Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors. J Med Chem (1990) 1.16
Observations on blood glucose and insulin determinations. Br Med J (1972) 1.16
Interphotoreceptor retinoid-binding protein and alpha-tocopherol preserve the isomeric and oxidation state of retinol. Photochem Photobiol (1992) 1.15
The fetus as an allograft: evidence for protective antibodies to HLA-linked paternal antigens. Lancet (1983) 1.15
Hallux-to-hand transfer. Hand (1975) 1.13
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther (1999) 1.13
Digital replantation: clinical experiences. Clin Orthop Relat Res (1978) 1.12
Tactile attention tasks enhance activation in somatosensory regions of parietal cortex: a positron emission tomography study. Cereb Cortex (1999) 1.12
Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol (1991) 1.12
Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology (1996) 1.12
Characterization of the glycosyltransferase enzyme from the Escherichia coli K5 capsule gene cluster and identification and characterization of the glucuronyl active site. J Biol Chem (1998) 1.11
Cyclosporine-induced fetotoxicity in the rat. Transplantation (1985) 1.10
Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemia-reperfusion injury. Kidney Int (2000) 1.10
Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs. Aliment Pharmacol Ther (2006) 1.09
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther (2001) 1.09
The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther (1999) 1.08
The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. Diabet Med (2007) 1.08
Chronic intestinal pseudo-obstruction in systemic lupus erythematosus due to intestinal smooth muscle myopathy. Lupus (2000) 1.07
Unsuspected pregnancy loss in healthy women. Lancet (1983) 1.07
Clinical replantation of digits. Plast Reconstr Surg (1973) 1.07
Observations on the oral glucose tolerance test in pregnancy. J Obstet Gynaecol Br Commonw (1968) 1.06
Endocrine cells in the human oxyntic mucosa. A histochemical study. Scand J Gastroenterol (1988) 1.06
The effects of oral iron supplementation on zinc and magnesium levels during pregnancy. Br J Obstet Gynaecol (1985) 1.05
Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme. Aliment Pharmacol Ther (2002) 1.05
Effect of iron supplementation on serum ferritin levels during and after pregnancy. Br J Obstet Gynaecol (1982) 1.04
Death during the first 90 days of dialysis: a case control study. Am J Kidney Dis (1995) 1.04
Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence? QJM (1996) 1.03
Biochemical and cytological changes in liquor amnii with advancing gestation. J Obstet Gynaecol Br Commonw (1969) 1.03
Can we improve early mortality in patients receiving renal replacement therapy? Kidney Int (2000) 1.02
Staphylococcal septicaemia, endocarditis, and osteomyelitis in dialysis and renal transplant patients. Postgrad Med J (1980) 1.01
Acute renal failure: factors influencing nephrology referral and outcome. QJM (1997) 1.01
Haematological changes during normal pregnancy: iron induced macrocytosis. Br J Obstet Gynaecol (1976) 1.00
New and old markers of progression of diabetic nephropathy. Diabetes Res Clin Pract (2008) 0.99
Relation between birth-weight and rupture-delivery interval. Lancet (1969) 0.99
SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure. Ann Neurol (2009) 0.98
The excretion of glucose during normal pregnancy. J Obstet Gynaecol Br Commonw (1972) 0.97
The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection. Helicobacter (2000) 0.97
Absorption of non-haem iron from food during normal pregnancy. BMJ (1994) 0.97
Serial hematologic changes and pregnancy outcome. Obstet Gynecol (1996) 0.97
Does random blood glucose sampling outdate testing for glycosuria in the detection of diabetes during pregnancy? Br Med J (Clin Res Ed) (1984) 0.96
Microvascular second toe transfer for digital reconstruction. J Hand Surg Am (1978) 0.95